Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00287963
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
topotecan hydrochloride
DRUG:
vinorelbine tartrate
Sponsor
Medical University of South Carolina